Fengyi Jin1, Claire M Vajdic2, Matthew Law1, Janaki Amin3, Marina van Leeuwen2, Skye McGregor1, I Mary Poynten1, David J Templeton1,4, Andrew E Grulich1. 1. The Kirby Institute. 2. Centre for Big Data Research in Health, University of New South Wales. 3. Department of Health Systems and Populations, Faculty of Medicine and Health Sciences, Macquarie University. 4. Sexual Health Service, Sydney Local Health District, Sydney and Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Abstract
BACKGROUND: Anal cancer incidence increased markedly in people living with HIV (PLWHIV) after the introduction of HAART, but in a few setting settings, recent declines have been reported. We report the incidence and time trends of anal cancer in PLWHIV in Australia. STUDY DESIGN: A data linkage study between the National HIV Registries and the Australian Cancer Database. METHODS: Cases of anal squamous cell carcinoma (ASCC) in Australians aged 16 years and above diagnosed with HIV between 1982 and 2012 were identified. Standardized incidence ratios (SIRs) were calculated to compare incidence with that of the general population. Poisson regression models were developed to describe the time trends of ASCC over time and to compare ASCC risk within subgroups of PLWHIV. RESULTS: Among 28 696 individuals, a total of 129 cases of ASCC were identified. The crude incidence was 36.3 per 100 000 person-years and it increased sharply from 14.8 to 62.1 per 100 000 person-years between 1982-1995 and 2009-2012 (P trend <0.001). The SIR was 35.3 (95% confidence interval 29.5-42.0), and there was an inverse association between SIR and increasing age (P trend <0.001). In multivariate analyses, ASCC incidence was significantly higher in recent years (P trend <0.001), in those who acquired HIV through male homosexual contact (P = 0.002), and in those who had a history of AIDS (P < 0.001). CONCLUSION: PLWHIV in Australia are at markedly higher risk of anal cancer. Unlike in some industrialized countries with a mature HIV epidemic, the incidence of anal cancer is still increasing in this population in Australia.
BACKGROUND:Anal cancer incidence increased markedly in people living with HIV (PLWHIV) after the introduction of HAART, but in a few setting settings, recent declines have been reported. We report the incidence and time trends of anal cancer in PLWHIV in Australia. STUDY DESIGN: A data linkage study between the National HIV Registries and the Australian Cancer Database. METHODS: Cases of anal squamous cell carcinoma (ASCC) in Australians aged 16 years and above diagnosed with HIV between 1982 and 2012 were identified. Standardized incidence ratios (SIRs) were calculated to compare incidence with that of the general population. Poisson regression models were developed to describe the time trends of ASCC over time and to compare ASCC risk within subgroups of PLWHIV. RESULTS: Among 28 696 individuals, a total of 129 cases of ASCC were identified. The crude incidence was 36.3 per 100 000 person-years and it increased sharply from 14.8 to 62.1 per 100 000 person-years between 1982-1995 and 2009-2012 (P trend <0.001). The SIR was 35.3 (95% confidence interval 29.5-42.0), and there was an inverse association between SIR and increasing age (P trend <0.001). In multivariate analyses, ASCC incidence was significantly higher in recent years (P trend <0.001), in those who acquired HIV through male homosexual contact (P = 0.002), and in those who had a history of AIDS (P < 0.001). CONCLUSION: PLWHIV in Australia are at markedly higher risk of anal cancer. Unlike in some industrialized countries with a mature HIV epidemic, the incidence of anal cancer is still increasing in this population in Australia.
Authors: Alexander Swart; Nicola S Meagher; Marina T van Leeuwen; Kun Zhao; Andrew Grulich; Limin Mao; Deborah Anne Randall; Louisa Degenhardt; Lucy Burns; Dianne O'Connell; Janaki Amin; Claire M Vajdic Journal: Aust N Z J Public Health Date: 2014-11-07 Impact factor: 2.939
Authors: Olivier Richel; Ramon P Van Der Zee; Colette Smit; Henry J C De Vries; Jan M Prins Journal: J Acquir Immune Defic Syndr Date: 2015-08-15 Impact factor: 3.731
Authors: Gypsyamber D'Souza; Dorothy J Wiley; Xiuhong Li; Joan S Chmiel; Joseph B Margolick; Ross D Cranston; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2008-08-01 Impact factor: 3.731
Authors: Andrew E Grulich; I Mary Poynten; Dorothy A Machalek; Fengyi Jin; David J Templeton; Richard J Hillman Journal: Sex Health Date: 2012-12 Impact factor: 2.706
Authors: Hamish McManus; Catherine C O'Connor; Mark Boyd; Jennifer Broom; Darren Russell; Kerrie Watson; Norman Roth; Phillip J Read; Kathy Petoumenos; Matthew G Law Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240
Authors: Sheela V Godbole; Karabi Nandy; Mansi Gauniyal; Pallavi Nalawade; Suvarna Sane; Shravani Koyande; Joy Toyama; Asha Hegde; Phil Virgo; Kishor Bhatia; Ramesh S Paranjape; Arun R Risbud; Sam M Mbulaiteye; Ronald T Mitsuyasu Journal: Medicine (Baltimore) Date: 2016-09 Impact factor: 1.889
Authors: Carmen Hidalgo-Tenorio; Concepción Gil-Anguita; Miguel Angel López Ruz; Mohamed Omar; Javier López-Hidalgo; Juan Pasquau Journal: PLoS One Date: 2019-10-24 Impact factor: 3.240
Authors: Carmen Hidalgo-Tenorio; Carmen Maria García-Martínez; Juan Pasquau; Mohamed Omar-Mohamed-Balgahata; Miguel López-Ruz; Javier López-Hidalgo; Concepción Gil-Anguita Journal: PLoS One Date: 2021-02-03 Impact factor: 3.240